Abstract
Genetic engineering has made the mouse an invaluable tool to address the function of individual genes in a targeted manner. Over the last decade it has become apparent that the genetic mouse strain background can significantly influence the phenotype of an engineered mouse. Therefore, it is essential to characterize the biology of the different wild-type background strains. In this study, we have compared mouse mammary gland involution in the 129S1 and C57BL/6 inbred strains and report significant differences at the molecular level with differential expression of Bcl2a1 (Bfl1), Trp53 (p53), Cebpb (C/EBPβ), and Cebpd (C/EBPδ). The C57BL/6 strain exhibits dynamic responses with induction of Trp53 and Cebpd and concomitant downregulation of Bcl2a1 during the first phase of involution. In contrast, expression of these genes does not change significantly in 129S1 mice. During the second phase, C57BL/6 glands contain more Cebpb than 129S1 glands. Nevertheless, involution proceeds morphologically with similar kinetics in both strains. The data demonstrate that the genetic response of mammary tissue varies significantly between 129S1 and C57BL/6. These results may provide a basis for the interpretation of strain-specific phenotypes in engineered mice and underline the importance of pure strains for large-scale expression studies with mutant mice.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Beck JA, Lloyd S, Hafezparast M, Lennon-Pierce M, Eppig JT, Festing MF and Fisher EM . (2000). Nat. Genet., 24, 23–25.
Darlington GJ, Ross SE and MacDougald OA . (1998). J. Biol. Chem., 273, 30057–30060.
D'Sa-Eipper C and Chinnadurai G . (1998). Oncogene, 16, 3105–3114.
D'Sa-Eipper C, Subramanian T and Chinnadurai G . (1996). Cancer Res., 56, 3879–3882.
Furth PA . (1999). J. Mammary Gland Biol. Neoplasia, 4, 123–127.
Gigliotti AP and DeWille JW . (1998). J. Cell Physiol., 174, 232–239.
Gigliotti AP, Johnson PF, Sterneck E and Dewille JW . (2003). Exp. Biol. Med., (Maywood), 228, 278–285.
Gross A, McDonnell JM and Korsmeyer SJ . (1999). Genes Dev., 13, 1899–1911.
Heermeier K, Benedict M, Li M, Furth P, Nunez G and Hennighausen L . (1996). Mech. Dev., 56, 197–207.
Hennighausen L and Robinson GW . (1998). Genes Dev., 12, 449–455.
Hodge DL, Martinez A, Julias JG, Taylor LS and Young HA . (2002). Mol. Cell Biol., 22, 1742–1753.
Howlett AR and Bissell MJ . (1993). Epithelial Cell Biol., 2, 79–89.
Jager R, Herzer U, Schenkel J and Weiher H . (1997). Oncogene, 15, 1787–1795.
Jerry DJ, Kuperwasser C, Downing SR, Pinkas J, He C, Dickinson E, Marconi S and Naber SP . (1998). Oncogene, 17, 2305–2312.
Li M, Hu J, Heermeier K, Hennighausen L and Furth PA . (1996). Cell Growth Differ., 7, 13–20.
Lund LR, Romer J, Thomasset N, Solberg H, Pyke C, Bissell MJ, Dano K and Werb Z . (1996). Development, 122, 181–193.
O'Reilly MA, Staversky RJ, Huyck HL, Watkins RH, LoMonaco MB, D'Angio CT, Baggs RB, Maniscalco WM and Pryhuber GS . (2000). Lab. Invest., 80, 1845–1854.
O'Rourke JP, Newbound GC, Hutt JA and DeWille J . (1999). J. Biol. Chem., 274, 16582–16589.
Quarrie LH, Addey CV and Wilde CJ . (1995). Cell Tissue Res., 281, 413–419.
Robinson GW, Johnson PF, Hennighausen L and Sterneck E . (1998). Genes Dev., 12, 1907–1916.
Schorr K, Li M, Bar-Peled U, Lewis A, Heredia A, Lewis B, Knudson CM, Korsmeyer SJ, Jager R, Weiher H and Furth PA . (1999a). Cancer Res, 59, 2541–2545.
Schorr K, Li M, Krajewski S, Reed JC and Furth PA . (1999b). J. Mammary Gland Biol. Neoplasia, 4, 153–164.
Seagroves TN, Krnacik S, Raught B, Gay J, Burgess-Beusse B, Darlington GJ and Rosen JM . (1998). Genes Dev., 12, 1917–1928.
Sibilia M and Wagner EF . (1995). Science, 269, 234–238.
Strange R, Friis RR, Bemis LT and Geske FJ . (1995). Methods in Cell Biology, Vol. 46. Schwartz LM, Osborne BA (eds) Academic Press: San Diego, pp. 355–368.
Strange R, Li F, Saurer S, Burkhardt A and Friis RR . (1992). Development, 115, 49–58.
Takiguchi M . (1998). Int. J. Exp. Pathol., 79, 369–391.
Threadgill DW, Dlugosz AA, Hansen LA, Tennenbaum T, Lichti U, Yee D, LaMantia C, Mourton T, Herrup K, Harris RC, Barnard JA, Yuspa SH, Coffey RJ and Magnuson T . (1995). Science, 269, 230–234.
Werner AB, de Vries E, Tait SW, Bontjer I and Borst J . (2002). J. Biol. Chem., 277, 22781–22788.
Wiseman BS and Werb Z . (2002). Science, 296, 1046–1049.
Zhang S, Ramsay ES and Mock BA . (1998). Proc. Natl. Acad. Sci., USA, 95, 2429–2434.
Zhang SL, DuBois W, Ramsay ES, Bliskovski V, Morse III HC, Taddesse-Heath L, Vass WC, DePinho RA and Mock BA . (2001). Mol. Cell Biol., 21, 310–318.
Acknowledgements
We thank Lori Warg and Barbara Shankle for expert technical assistance, Doug Powell for statistical analysis, Karen Vousden and Lothar Hennighausen for cDNA probes, and Lino Tessarollo for critical reading of the manuscript. The cDNAs for Mmp3, Plat, and Clu were obtained from the American Type Culture Collection.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Thangaraju, M., Sharan, S. & Sterneck, E. Comparison of mammary gland involution between 129S1 and C57BL/6 inbred mouse strains: differential regulation of Bcl2a1, Trp53, Cebpb, and Cebpd expression. Oncogene 23, 2548–2553 (2004). https://doi.org/10.1038/sj.onc.1207363
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207363
Keywords
This article is cited by
-
BCL2A1: the underdog in the BCL2 family
Cell Death & Differentiation (2012)
-
Fog2 excision in mice leads to premature mammary gland involution and reduced Esr1 gene expression
Oncogene (2007)